EPM2AIP1 Antikörper
Kurzübersicht für EPM2AIP1 Antikörper (ABIN2720297)
Target
Alle EPM2AIP1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Produktmerkmale
- Homo sapiens EPM2A (laforin) interacting protein 1 (EPM2AIP1)
-
Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogen
- Full length human recombinant protein of human EPM2AIP1(NP_055620) produced in HEK293T cell.
-
Isotyp
- IgG2b
-
-
-
-
Applikationshinweise
- WB 1:2000, IHC 1:150, FLOW 1:100,
-
Kommentare
-
The concentration of the product may vary between diferrent lots.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
-
- EPM2AIP1 (EPM2A (Laforin) Interacting Protein 1 (EPM2AIP1))
-
Andere Bezeichnung
- EPM2AIP1
-
Hintergrund
- The EPM2A gene, which encodes laforin, is mutated in an autosomal recessive form of adolescent progressive myoclonus epilepsy. The protein encoded by this gene binds to laforin, but its function is not known. This gene is intronless. COMPLETENESS: complete on the 3' end.
-
Molekulargewicht
- 70.2 kDa
-
Gen-ID
- 9852
-
NCBI Accession
- NM_014805
-
HGNC
- 9852
Target
-